Χώρα: Ιρλανδία
Γλώσσα: Αγγλικά
Πηγή: HPRA (Health Products Regulatory Authority)
A/CALIFORNIA/7/2009/(H1N1)PDM - LIKE STRAIN (A/CALIFORNIA/7/2009, NYMC X-179A), A/TEXAS/50/2012/(H3N2) - LIKE STRAIN (A/TEXAS/50/2012, NYMC X-223A), B/BRISBANE/60/2008 (VICTORIA LINEAGE), B/MASSACHUSSETS/2/2012 (YAMAGATA LINEAGE)
Sanofi Pasteur MSD Ltd
J07BB02
A/CALIFORNIA/7/2009/(H1N1)PDM - LIKE STRAIN (A/CALIFORNIA/7/2009, NYMC X-179A), A/TEXAS/50/2012/(H3N2) - LIKE STRAIN (A/TEXAS/50
15 Microgram
Solution for injection in pre-filled syringe
Product subject to prescription which may not be renewed (A)
Influenza vaccines
Transfer Pending
2016-07-15
PACKAGE LEAFLET: INFORMATION FOR THE USER QUADRIVALENT INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED), SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE Quadrivalent influenza vaccine (split virion, inactivated) This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU OR YOUR CHILD ARE VACCINATED BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This vaccine has been prescribed for you or your child only. Do not pass it on to others. - If you or your child get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Quadrivalent Influenza Vaccine (split virion, inactivated) is and what it is used for 2. What you need to know before you or your child use Quadrivalent Influenza Vaccine (split virion, inactivated) 3. How to use Quadrivalent Influenza Vaccine (split virion, inactivated) 4. Possible side effects 5. How to store Quadrivalent Influenza Vaccine (split virion, inactivated) 6. Contents of the pack and other information 1. WHAT QUADRIVALENT INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) IS AND WHAT IT IS USED FOR Quadrivalent Influenza Vaccine (split virion, inactivated) is a vaccine. This vaccine helps to protect you or your child against influenza (flu). The use of Quadrivalent Influenza Vaccine (split virion, inactivated) should be based on official recommendations. When a person is given Quadrivalen Διαβάστε το πλήρες έγγραφο
SUMMARY OF PRODUCT CHARACTERISTICS This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions. 1 NAME OF THE MEDICINAL PRODUCT Quadrivalent Influenza Vaccine (split virion, inactivated), suspension for injection in pre-filled syringe Quadrivalent influenza vaccine (split virion, inactivated) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Per 0.5 ml dose * propagated in fertilised hens’ eggs from healthy chicken flocks ** haemagglutinin This vaccine complies with the WHO recommendations (Northern Hemisphere) and EU decision for the 2014/2015 season. For the full list of excipients, see Section 6.1. Quadrivalent Influenza Vaccine (split virion, inactivated) may contain traces of eggs, such as ovalbumin, and of neomycin, formaldehyde and octoxinol-9, which are used during the manufacturing process (see Section 4.3). 3 PHARMACEUTICAL FORM Suspension for injection in pre-filled syringe. The vaccine, after shaking gently, is a colourless opalescent liquid. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Quadrivalent Influenza Vaccine (split virion, inactivated) is indicated for active immunisation of adults and children from 3 years of age and older for the prevention of influenza disease caused by the two influenza A virus subtypes and the two influenza B virus types contained in the vaccine. The use of Quadrivalent Influenza Vaccine (split virion, inactivated) should be based on official recommendations. Influenza virus (inactivated, split) of the following strains*: A/California/7/2009 (H1N1)pdm09 - like strain (A/California/7/2009, NYMC X-179A) …15 micrograms HA** A/Texas/50/2012 (H3N2) - like strain (A/ Διαβάστε το πλήρες έγγραφο